Immunomodulatory effects of ultra-low-dose interleukin-2 in cancer patients: a phase-IB study.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/AFBD0C9D.svg?ark=w1%2F20260515%2FAFBD0C9D)](https://nobleid.org/work/w1/20260515/AFBD0C9D)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors